We are live on ! Find out more
XGN icon

Exagen
XGN

36 hedge funds and large institutions have $97.7M invested in Exagen in 2019 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

76% more capital invested

Capital invested by funds: $55.5M → $97.7M (+$42.1M)

64% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 14

40% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 5

33% more funds holding

Funds holding: 27 → 36 (+9)

0.84% more ownership

Funds ownership: 29.77% → 30.61% (+0.84%)

Holders
36
Holders Change
+9
Holders Change %
+33.33%
% of All Funds
0.71%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
7
Reduced
5
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
FCM
Farallon Capital Management
California
+$3.81M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$3.74M
3
RI
RTW Investments
New York
+$3.69M
4
BlackRock
BlackRock
New York
+$2.17M
5
Calamos Advisors
Calamos Advisors
Illinois
+$1.19M

Top Sellers

Rank Fund Capital Flow
1
BC
Broadfin Capital
New York
-$4.82M
2
MIM
Monashee Investment Management
Massachusetts
-$1.78M
3
SCM
Sio Capital Management
New York
-$1.32M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$1.05M
5
Norges Bank
Norges Bank
Norway
-$697K
Name Holding Trade Value Shares
Change 		Change in
Stake
RI
1
RTW Investments
New York
$18.3M +$3.69M +207,313 +41%
FCM
2
Farallon Capital Management
California
$14.7M +$3.81M +214,363 +59%
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$12.1M -$398K -22,370 -4%
Victory Capital Management
4
Victory Capital Management
Texas
$9.86M -$657K -36,926 -9%
WA
5
Wasatch Advisors
Utah
$8.93M -$345K -19,415 -5%
NCGI
6
Next Century Growth Investors
Minnesota
$6.62M +$1.17M +65,805 +34%
Vanguard Group
7
Vanguard Group
Pennsylvania
$6.23M +$3.74M +210,083 +600%
Calamos Advisors
8
Calamos Advisors
Illinois
$5.5M +$1.19M +66,825 +45%
BlackRock
9
BlackRock
New York
$3.1M +$2.17M +121,964 New
Russell Investments Group
10
Russell Investments Group
United Kingdom
$2.91M +$926K +52,059 +83%
PCM
11
Perkins Capital Management
Minnesota
$2.18M -$28.5K -1,600 -2%
MAG
12
Millrace Asset Group
Pennsylvania
$1.57M -$146K -8,200 -12%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$1.38M +$968K +54,432 New
Northern Trust
14
Northern Trust
Illinois
$939K +$658K +36,971 New
EI
15
EAM Investors
California
$808K +$566K +31,807 New
TD Asset Management
16
TD Asset Management
Ontario, Canada
$641K – – –
State Street
17
State Street
Massachusetts
$586K +$410K +23,065 New
Squarepoint
18
Squarepoint
New York
$388K +$272K +15,264 New
William Blair & Company
19
William Blair & Company
Illinois
$254K +$178K +10,000 New
Morgan Stanley
20
Morgan Stanley
New York
$132K +$70.5K +3,963 +322%
California State Teachers Retirement System (CalSTRS)
21
California State Teachers Retirement System (CalSTRS)
California
$128K +$90K +5,057 New
New York State Common Retirement Fund
22
New York State Common Retirement Fund
New York
$117K +$81.8K +4,600 New
UBS Group
23
UBS Group
Switzerland
$104K +$72.8K +4,089 New
AIG
24
American International Group
New York
$53K +$36.9K +2,074 New
Deutsche Bank
25
Deutsche Bank
Germany
$28K +$19.7K +1,109 New
1
2

XGN Hedge Fund Activity: Q4 2019 in Review

36 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Exagen (XGN) for Q4 2019, worth a combined $97.7M — up 76% from $55.5M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new XGN positions and 14 closed out — a net gain of 9 holders — while 7 added to existing stakes and 5 trimmed.

The largest buyer was Farallon Capital Management, adding an estimated $3.81M. The largest seller was Broadfin Capital, exiting entirely with an estimated $4.82M sold.

  • 36 institutional investors held Exagen (XGN) as of Q4 2019, up from 27 in Q3 2019.
  • Funds reported $97.7M of Exagen stock for Q4 2019, up 76% quarter-over-quarter.
  • 23 funds opened new Exagen positions in Q4 2019 and 14 closed out, a net change of +9 holders.
  • The largest Exagen buyer in Q4 2019 was Farallon Capital Management, an estimated $3.81M added.
  • The largest Exagen seller in Q4 2019 was Broadfin Capital, an estimated $4.82M sold.

Based on aggregated 13F filings for Q4 2019.